Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 741

1.

Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in 60Co-gamma-photon-irradiated and sham-irradiated mice.

Brook I, Germana A, Giraldo DE, Camp-Hyde TD, Bolduc DL, Foriska MA, Elliott TB, Thakar JH, Shoemaker MO, Jackson WE, Ledney GD.

J Antimicrob Chemother. 2005 Dec;56(6):1074-80. Epub 2005 Oct 20.

PMID:
16239289
[PubMed - indexed for MEDLINE]
Free Article
2.

Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without (60)Co gamma-photon irradiation.

Brook I, Giraldo DE, Germana A, Nicolau DP, Jackson WE, Elliott TB, Thakar JH, Shoemaker MO, Ledney GD.

J Med Microbiol. 2005 Dec;54(Pt 12):1157-62.

PMID:
16278429
[PubMed - indexed for MEDLINE]
Free Article
3.

Susceptibility of irradiated mice to Bacillus anthracis sterne by the intratracheal route of infection.

Brook I, Elliott TB, Harding RA, Bouhaouala SS, Peacock SJ, Ledney GD, Knudson GB.

J Med Microbiol. 2001 Aug;50(8):702-11.

PMID:
11478674
[PubMed - indexed for MEDLINE]
Free Article
4.

Antimicrobial therapy for bacillus anthracis-induced polymicrobial infection in (60)Co gamma-irradiated mice.

Elliott TB, Brook I, Harding RA, Bouhaouala SS, Shoemaker MO, Knudson GB.

Antimicrob Agents Chemother. 2002 Nov;46(11):3463-71.

PMID:
12384351
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.

Piercy T, Steward J, Lever MS, Brooks TJ.

J Antimicrob Chemother. 2005 Dec;56(6):1069-73. Epub 2005 Oct 13.

PMID:
16223941
[PubMed - indexed for MEDLINE]
Free Article
6.

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.

PMID:
17005989
[PubMed - indexed for MEDLINE]
Free Article
7.

Effective antiprotease-antibiotic treatment of experimental anthrax.

Popov SG, Popova TG, Hopkins S, Weinstein RS, MacAfee R, Fryxell KJ, Chandhoke V, Bailey C, Alibek K.

BMC Infect Dis. 2005 Apr 8;5:25.

PMID:
15819985
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

WR-151327 increases resistance to Klebsiella pneumoniae infection in mixed-field- and gamma-photon-irradiated mice.

Ledney GD, Elliott TB, Harding RA, Jackson WE 3rd, Inal CE, Landauer MR.

Int J Radiat Biol. 2000 Feb;76(2):261-71.

PMID:
10716647
[PubMed - indexed for MEDLINE]
9.

Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.

Thadepalli H, Chuah SK, Gollapudi S.

Chemotherapy. 2004 Jun;50(2):76-80.

PMID:
15211081
[PubMed - indexed for MEDLINE]
10.

Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in vitro pharmacodynamic system.

Louie A, Vanscoy BD, Heine HS 3rd, Liu W, Abshire T, Holman K, Kulawy R, Brown DL, Drusano GL.

Antimicrob Agents Chemother. 2012 Jan;56(1):513-7. doi: 10.1128/AAC.05724-11. Epub 2011 Nov 7.

PMID:
22064542
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.

Karginov VA, Robinson TM, Riemenschneider J, Golding B, Kennedy M, Shiloach J, Alibek K.

FEMS Immunol Med Microbiol. 2004 Jan 15;40(1):71-4.

PMID:
14734189
[PubMed - indexed for MEDLINE]
12.

Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model.

Louie A, VanScoy BD, Brown DL, Kulawy RW, Heine HS, Drusano GL.

Antimicrob Agents Chemother. 2012 Mar;56(3):1229-39. doi: 10.1128/AAC.01109-10. Epub 2011 Dec 12.

PMID:
22155821
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Lethality in a murine model of pulmonary anthrax is reduced by combining nuclear transport modifier with antimicrobial therapy.

Veach RA, Zienkiewicz J, Collins RD, Hawiger J.

PLoS One. 2012;7(1):e30527. doi: 10.1371/journal.pone.0030527. Epub 2012 Jan 26.

PMID:
22291977
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Anthrax-protective effects of yeast beta 1,3 glucans.

Kournikakis B, Mandeville R, Brousseau P, Ostroff G.

MedGenMed. 2003 Mar 21;5(1):1.

PMID:
12827062
[PubMed - indexed for MEDLINE]
Free Article
16.

Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolones.

Steward J, Lever MS, Simpson AJ, Sefton AM, Brooks TJ.

J Antimicrob Chemother. 2004 Jul;54(1):95-9. Epub 2004 May 26.

PMID:
15163650
[PubMed - indexed for MEDLINE]
Free Article
17.

Comparative safety and efficacy against Bacillus anthracis of protective antigen and live vaccines in mice.

Welkos SL, Friedlander AM.

Microb Pathog. 1988 Aug;5(2):127-39.

PMID:
3148815
[PubMed - indexed for MEDLINE]
18.

Post-exposure therapy of inhalational anthrax in the common marmoset.

Nelson M, Stagg AJ, Stevens DJ, Brown MA, Pearce PC, Simpson AJ, Lever MS.

Int J Antimicrob Agents. 2011 Jul;38(1):60-4. doi: 10.1016/j.ijantimicag.2011.03.003. Epub 2011 May 6.

PMID:
21530184
[PubMed - indexed for MEDLINE]
19.

Comparing the protective effects of ciprofloxacin, moxifloxacin and levofloxacin in mice with lipopolysaccharide-induced acute lung injuries.

Huang HC, Shieh CC, Yu WL, Cheng KC, Chen CC, Chang ST, Chuang YC.

Respirology. 2008 Jan;13(1):47-52. doi: 10.1111/j.1440-1843.2007.01192.x.

PMID:
18197910
[PubMed - indexed for MEDLINE]
20.

Pathogenesis and genetic control of resistance to the Sterne strain of Bacillus anthracis.

Welkos SL, Friedlander AM.

Microb Pathog. 1988 Jan;4(1):53-69.

PMID:
3143893
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk